Anaphylactic Shock Caused by Haemocoagulase Injection in China

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2017 Apr 18

PMID 28413507

Authors

Haiwei Yang

Liming Yang

De-Wang Wang

Ji-Fu Wei

Shaoheng He

Affiliations

Soon will be listed here.

Abstract

Haemocoagulase injection is a mixture of purified enzymes isolated from the venom of , which is used for the prevention and treatment of haemorrhage. It is a relatively safe pharmacological agent that does not require a skin test prior to administration. However, following a literature search, 14 reported cases of anaphylactic shock caused by haemocoagulase injection were identified, including one lethal case in China. Using SDS-PAGE and protein identification, four primary components in haemocoagulase injection were characterized, including one metalloproteinase, which may be a thromboplastin-like enzyme, and two serine proteinases, which may be thrombin-like enzymes. Administering concentrated haemocoagulase injections failed to provoke a positive skin reaction in allergic patients. Basophil activation tests revealed that haemocoagulase injections did not upregulate cluster of differentiation 63 or C-C chemokine receptor type 3 expression. These findings suggest that haemocoagulase injection may cause fetal anaphylaxis. Although it is difficult to determine a clear conclusion without being able to evaluate the patients that underwent haemocoagulase injection-induced shock, it is unlikely that the venomous components of haemocoagulase injection cross-react with common allergens in allergic patients. It is possible that haemocoagulase injection-induced anaphylaxis is caused by its additive components, such as mannitol and succinylated gelatin.

References

Anderson W, Lipworth B . Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids. Lung. 2012; 190(5):513-21. DOI: 10.1007/s00408-012-9396-6. View

He S, Gaca M, Walls A . A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther. 1998; 286(1):289-97. View

An S, Chen L, Wei J, Yang X, Ma D, Xu X . Purification and characterization of two new allergens from the venom of Vespa magnifica. PLoS One. 2012; 7(2):e31920. PMC: 3288059. DOI: 10.1371/journal.pone.0031920. View

de Medeiros C, Barbaro K, Lira M, Franca F, Zaher V, Kokron C . Predictors of Bothrops jararaca venom allergy in snake handlers and snake venom handlers. Toxicon. 2008; 51(4):672-80. DOI: 10.1016/j.toxicon.2007.11.022. View

Clarke R, Sadleir P, Van Niekerk A, Platt P . Quantification of volume loss and haemodynamic changes of Gelofusine-induced anaphylaxis during cardiopulmonary bypass. Anaesth Intensive Care. 2011; 39(3):492-5. DOI: 10.1177/0310057X1103900324. View

An S, Ma D, Wei J, Yang X, Yang H, Yang H . A novel allergen Tab y 1 with inhibitory activity of platelet aggregation from salivary glands of horseflies. Allergy. 2011; 66(11):1420-7. DOI: 10.1111/j.1398-9995.2011.02683.x. View

Wei J, Wei X, Mo Y, He S . Induction of microvascular leakage and histamine release by promutoxin, an Arg49 phospholipase A2. Toxicon. 2009; 55(4):888-96. DOI: 10.1016/j.toxicon.2009.12.016. View

Castro H, Zingali R, Albuquerque M, Pujol-Luz M, Rodrigues C . Snake venom thrombin-like enzymes: from reptilase to now. Cell Mol Life Sci. 2004; 61(7-8):843-56. PMC: 11138602. DOI: 10.1007/s00018-003-3325-z. View

Sanz M, Gamboa P, Antepara I, Uasuf C, Vila L, Garcia-Aviles C . Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy. 2002; 32(2):277-86. DOI: 10.1046/j.1365-2222.2002.01305.x. View

10.

Madero M, Gamez C, Madero M, Fernandez-Nieto M, Sastre J, Del Pozo V . Characterization of allergens in four South American snake species. Int Arch Allergy Immunol. 2009; 150(3):307-10. DOI: 10.1159/000222684. View

11.

Wei J, Mo Y, Qiao L, Wei X, Chen H, Xie H . Potent histamine-releasing activity of atrahagin, a novel snake venom metalloproteinase. Int J Biochem Cell Biol. 2005; 38(4):510-20. DOI: 10.1016/j.biocel.2005.10.011. View

12.

Wei J, Wei X, Mo Y, He S . Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2. BMC Immunol. 2009; 10:21. PMC: 2681446. DOI: 10.1186/1471-2172-10-21. View

13.

He S, Gaca M, McEUEN A, Walls A . Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther. 1999; 291(2):517-23. View

14.

Kang O, Choi Y, Park H, Kang C, Song B, Choi S . Inhibition of trypsin-induced mast cell activation by acanthoic acid. J Ethnopharmacol. 2006; 105(3):326-31. DOI: 10.1016/j.jep.2005.10.032. View

15.

Hegde V, Venkatesh Y . Anaphylaxis to excipient mannitol: evidence for an immunoglobulin E-mediated mechanism. Clin Exp Allergy. 2004; 34(10):1602-9. DOI: 10.1111/j.1365-2222.2004.02079.x. View

16.

Wei J, Wei X, Mo Y, Yang H, He S . Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2. Biomed Res Int. 2013; 2013:206061. PMC: 3591241. DOI: 10.1155/2013/206061. View

17.

Sainte-Laudy J, VALLON C, Guerin J . [Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis]. Allerg Immunol (Paris). 1994; 26(6):211-4. View

18.

Apostolou E, Deckert K, Puy R, Sandrini A, de Leon M, Douglass J . Anaphylaxis to Gelofusine confirmed by in vitro basophil activation test: a case series. Anaesthesia. 2006; 61(3):264-8. DOI: 10.1111/j.1365-2044.2005.04529.x. View

19.

Dugina T, Kiseleva E, Glusa E, Strukova S . Activation of mast cells induced by agonists of proteinase-activated receptors under normal conditions and during acute inflammation in rats. Eur J Pharmacol. 2003; 471(2):141-7. DOI: 10.1016/s0014-2999(03)01752-7. View

20.

Prescott R, Potter P . Hypersensitivity to airborne spitting cobra snake venom. Ann Allergy Asthma Immunol. 2005; 94(5):600-3. DOI: 10.1016/S1081-1206(10)61140-4. View